T. Kumar

A CTC-Cluster-Specific Signature Derived from OMICS Analysis of Patient-Derived Xenograft Tumors Predicts Outcomes in Basal-Like Breast Cancer

Jason T. George, R. Schiff, C. Creighton, 2019, Journal of clinical medicine.